Atlas Trials

JS212 in Combination With JS111 as First-Line Treatment in EGFR-Mutant Advanced NSCLC

Clinical trial NCT07714304 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07714304
Sponsor
Huan Zhou
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
NSCLC Harboring EGFR Mutations
Start date
2026-07-13
Primary completion
2026-11-13
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.